Get the Daily Brief
Latest Biotech News
Iovance Biotherapeutics Restructures After Disappointing Cell Therapy Sales
Iovance announced a workforce reduction of less than 20 percent following a slow commercial uptake of its tumor infiltrating lymphocyte (TIL) therapy, Amtagvi, approved for advanced melanoma....
Quantum-Si Hits NIH Funding Roadblocks, Sees Revenue Dip
Proteomics technology developer Quantum-Si reported a 5 percent year-over-year revenue decline in Q2 2025, attributed primarily to funding constraints from the NIH that slowed capital sales...
Advancements in Pediatric Cancer Genomics Consortium Launch
Boston Children’s Hospital, Dana-Farber Cancer Institute, and Broad Clinical Labs have joined forces to establish BrightSeq, a clinical research consortium delivering integrated tissue and liquid...
HHS Halts $500M in mRNA Vaccine Funding Amid Political Shift
The U.S. Department of Health and Human Services (HHS) announced a sweeping cancellation of nearly $500 million in contracts for messenger RNA (mRNA) vaccine research under the Biomedical Advanced...
Strand Therapeutics Raises $153M for Programmable mRNA Cancer Drugs
Biotech startup Strand Therapeutics secured $153 million in Series B funding to advance its programmable mRNA therapeutics platform aimed at treating solid tumors. Founded on research from MIT,...
Eli Lilly’s Oral GLP-1 Obesity Pill Shows Modest Efficacy
Eli Lilly’s experimental oral GLP-1 receptor agonist, orforglipron, demonstrated up to 12.4% mean weight loss at 72 weeks in phase 3 trials involving adults with obesity or overweight status and...
Novo Nordisk Faces Leadership Change and Pipeline Challenges
Novo Nordisk is undergoing a leadership transition with Maziar Mike Doustdar set to assume CEO duties amid intensifying competition in the GLP-1 obesity and diabetes drug market. Sales growth has...
Merck’s Strategic Moves: Verona Buyout and Alzheimer’s Antibody Recommendation
Merck completed a $10 billion acquisition of Verona Pharma, acquiring the COPD drug ensifentrine after minimal competition during the bidding process. The acquisition consolidates Merck's presence...
Advancements in Pediatric Oncology Genomics and Diagnostics
A trio of leading institutions—Boston Children’s Hospital, Dana-Farber Cancer Institute, and Broad Clinical Labs—launched an integrated pediatric cancer genomics initiative named BrightSeq. The...
Breakthroughs in Neurodegenerative Disease Mechanisms and Therapies
Emerging research reveals lithium deficiency in the brain as a pivotal factor in Alzheimer’s disease progression, with novel lithium compounds capable of reversing pathology in mouse models....
Innovations in Energy Storage Materials and Battery Management
Recent studies report significant advancements in lithium-ion and sodium-ion battery technologies. Novel cathode materials such as Nb-doped lithium-rich oxides and Ti-doped tungsten trioxide thin...
Digital Transformation and AI Integration in Biopharma Manufacturing
Biopharmaceutical companies increasingly embrace digital technologies to optimize manufacturing and streamline operations. Sanofi advances its digital drugmaking transformation via AI-driven...
Eli Lilly Reshuffles Pain and Obesity Pipelines Amid Mixed Trial Outcomes
Eli Lilly is strategically pivoting its drug development portfolio, notably axing midstage pain candidates and introducing new early-phase assets following recent clinical trial results. The...
US HHS Ends mRNA Vaccine Funding, Sparking Industry Concerns
The US Department of Health and Human Services (HHS) announced termination of 22 contracts totaling nearly $500 million for mRNA vaccine development under BARDA, reflecting a significant shift...
Iovance Biotherapeutics Restructures After Tepid TIL Cell Therapy Sales
Iovance Biotherapeutics announced layoffs of less than 20% of its workforce following a slow commercial launch of Amtagvi, a tumor-infiltrating lymphocyte (TIL) cell therapy approved earlier in...
Advanced Imaging and Forensic Techniques Refine Pediatric and Postmortem Analyses
Recent studies underscore significant progress in radiological and forensic imaging technologies enhancing pediatric and postmortem evaluations. Techniques such as ultrasound-guided hydrostatic...
Breakthroughs in Microglia Replacement and Neurodegeneration Therapies
Innovative research from Stanford Medicine and collaborators has demonstrated a promising therapeutic avenue for neurodegenerative lysosomal storage diseases such as Tay-Sachs and Sandhoff disease...
Genomic and Molecular Insights Drive Cancer and Disease Research
Recent studies highlight transformative genomic and molecular discoveries across oncology and beyond. Multi-omics investigations reveal T-cell exhaustion mechanisms and galectin-9 targets in...
Innovations in Energy Storage and Battery Technology
Cutting-edge research in battery materials and energy storage continues to push boundaries in performance and sustainability. Advancements include the development of Nb-doped lithium-rich oxides,...
Emerging Microbiome and Infectious Disease Research
Groundbreaking studies continue to elucidate the complex roles of microbiomes and infectious agents across human health and agriculture. Discoveries include the influence of gut microbiota on...